Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIIB061 as Add-On Therapy in Relapsing Multiple Sclerosis
NCT04079088Phase 2Withdrawn
- Sponsor
- Biogen
- Start
- Jun 2021
- Primary completion
- Sep 2024
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of BIIB061 in multiple sclerosis (MS), sponsored by Biogen. Planned start Jun 2021; status: withdrawn.
02
Drugs
BIIB061
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT04079088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04079088.